Nebivolol, known by brand names such as Nebicyl and Bystolic, is a selective β1-adrenergic receptor blocker that also has nitric oxide-dependent vasodilatory properties. It is widely used in the treatment of hypertension due to its unique mechanism of action and favorable side effect profile. The drug was first introduced in Germany in 1997 and later gained approval in the United States in 2007 for the management of high blood pressure. Although it is not yet available in China, patients in other countries can benefit from its therapeutic effects under medical supervision.

适应症

Nebivolol is primarily indicated for the treatment of hypertension. Its ability to lower blood pressure helps reduce the risk of serious cardiovascular events such as stroke and heart attack. The drug can be used as monotherapy or in combination with other antihypertensive medications to achieve optimal blood pressure control. Clinical trials have shown that nebilol can effectively manage hypertension, making it a valuable option for healthcare providers.

高血压管理

Nebivolol is effective in lowering both systolic and diastolic blood pressure. By blocking β1-adrenergic receptors, it reduces the heart rate and cardiac output, leading to a decrease in blood pressure. Additionally, its vasodilatory properties help relax blood vessels, further contributing to the reduction of systemic vascular resistance. This dual mechanism makes nebilol a versatile and effective antihypertensive agent.

联合治疗

In cases where monotherapy with nebilol does not achieve the desired blood pressure reduction, the drug can be combined with other antihypertensive agents. Common combinations include thiazide diuretics, angiotensin-converting enzyme (ACE) inhibitors, and calcium channel blockers. These combinations can enhance the overall effectiveness of blood pressure control while minimizing the risk of side effects.

用法用量与注意事项

The dosing of nebilol should be tailored to the individual patient's needs and response. The initial dose is typically 5 mg once daily, which can be adjusted based on blood pressure response. The maximum recommended dose is 40 mg per day. Patients should take the medication at the same time each day to maintain consistent blood levels. It is important to follow the prescribing physician's instructions closely and not to alter the dosage without medical guidance.

用法用量

Nebivolol is available in tablet form, and the tablets are usually taken orally with or without food. The tablets should be swallowed whole and not crushed or chewed. The drug's bioavailability ranges from 12% to 96%, and it reaches peak blood concentration within 0.5 to 2 hours after ingestion. The half-life of the active isomer (d-nebilol) is approximately 12 hours in extensive metabolizers and 19 hours in poor metabolizers, indicating the need for careful monitoring in individuals with CYP2D6 polymorphisms.

不良反应

The most common adverse reactions associated with nebilol use include headache and fatigue. Other potential side effects may include dizziness, bradycardia (slow heart rate), and hypotension (low blood pressure). In rare cases, more severe side effects such as allergic reactions, liver function abnormalities, and respiratory issues may occur. Patients should report any unusual symptoms to their healthcare provider immediately.

注意事项

Patients using nebilol should undergo regular monitoring of blood pressure and heart rate. Sudden discontinuation of the medication, especially in those with coronary artery disease, can lead to severe complications such as worsening angina, myocardial infarction, and ventricular arrhythmias. Therefore, when discontinuing nebilol, it should be tapered gradually over 1 to 2 weeks under medical supervision.

Special caution is advised for patients with certain medical conditions. For example, those with severe renal impairment may require dose adjustments due to reduced renal clearance. Similarly, patients with moderate to severe liver dysfunction may need to have their doses reduced because of decreased metabolism. Pregnant and breastfeeding women should consult their doctors before using nebilol, as its safety in these populations is not well-established.

Nebivolol should be stored at a temperature between 20°C and 25°C in a closed, light-resistant container with a child-resistant cap. The drug has a shelf life of 24 months. Patients should avoid using nebilol concurrently with other β-blockers and certain drugs that may interact with it, such as CYP2D6 inhibitors, calcium channel blockers, and amiodarone, to prevent excessive cardiovascular depression.